Forward-looking statements include, but are not limited to, statements about the progress of RAPT’s oncology and inflammation programs and the interpretation of topline results from the Phase 1b trial of RPT193. Each of these statements is based only on current information, assumptions and expectations that are inherently subject to change and involve a number of risks and uncertainties. These statements relate to future events and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future performances or achievements expressed or implied by the forward-looking statements. This press release contains forward-looking statements. The Company is also pursuing a range of targets that are in the discovery stage of development. RAPT has discovered and advanced two unique drug candidates, FLX475 and RPT193, each targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of cancer and inflammation, respectively.
Utilizing its proprietary discovery and development engine, the Company is developing highly selective small molecules designed to modulate the critical immune drivers underlying these diseases. 22.While a handful had already tested positive for the virus, this latest case is the first involving a hamster in the care of a pet-owner that had tested positive.Despite a public outcry against the crackdown, authorities urged pet-owners to continue to hand over their tiny furry pets given the increasing health risks.The government described the outcry as "irrational".In response, thousands of people have offered to adopt unwanted hamsters.Meanwhile, 140 new infections were reported in Hong Kong on Sunday - and there are no signs of the government easing the restrictions.RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Hong Kong authorities on Sunday (January 23) said one hamster surrendered by pet-owners had tested positive for the COVID-19 virus, while over 2,200 hamsters had been culled as the city grappled to contain an outbreak.On Tuesday (January 18) officials ordered the killing of hamsters from dozens of pet stores after tracing a coronavirus outbreak to a worker at a shop.People were asked to surrender any hamsters bought on or after Dec. RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.
To access the live webcast and subsequent archived recording of the company presentation, please visit the RAPT Therapeutics website at. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the UBS Global Healthcare Virtual Conference on Monday, at 3:00 pm Eastern Time. SOUTH SAN FRANCISCO, Calif., (GLOBE NEWSWIRE) - RAPT Therapeutics, Inc.